Tag: biotechnology
-
Grant Funds Research on Nanotech Cancer Treatments
1 September 2015. National Cancer Institute is renewing its support for a Northwestern University research center advancing nanotechnology to design new cancer treatments. The Northwestern University Center for Cancer Nanotechnology Excellence is the recipient of a new five-year, $11.7 million grant from National Cancer Institute, part of National Institutes of Health. The Center for Cancer…
-
FDA Proposes Guidance, Rule on Biosimilar Naming
28 August 2015. The U.S. Food and Drug Administration proposed new guidance yesterday to provide a common, nonproprietary naming system for generic forms of biologic treatments, known as biosimilars. The agency also proposed a rule applying the system to six biologics and biosimilars already approved, announced with the guidance in a blog post on the…
-
Trial Shows Response to Antibody Treating Multiple Myeloma
27 August 2015. An early-stage clinical trial shows some patients receiving an engineered antibody to attack multiple myeloma cancer cells experienced at least a partial remission of their disease. Results of the study, led by oncologist Paul Richardson of Dana-Farber Cancer Institute and Harvard Medical School, appeared yesterday in New England Journal of Medicine. Multiple…
-
Pharma, Research Group Partner on Meningitis Therapy
26 August 2016. A collaboration between a company developing anti-fungal drugs and research group specializing in fungal infections aims to advance a new type of therapy for cryptococcal meningitis, a life-threatening infection affecting the brain and spinal cord. Financial details of the partnership between Viamet Pharmaceuticals in Research Triangle Park, North Carolina and Mycoses Study Group Education and Research Consortium in Birmingham,…
-
Small Business Grant Funds Preclinical Lupus Research
24 August 2015. A grant from National Institute of Allergy and Infectious Diseases is funding preclinical research by a biotechnology company on stem cells as a therapy for a type of lupus. The $225,000 grant from NIAID, part of National Institutes of Health, is made to Ocata Therapeutics Inc. of Marlborough, Massachusetts under the institute’s…
-
Synthetic Biology Company Raises $200 Million in IPO
21 August 2015. Intrexon Corp., a company developing genomic solutions with synthetic biology, raised some $200 million in its initial public stock offering. The Germantown, Maryland enterprise issued 4,878,049 shares of common stock priced at $41.00, and traded on the New York Stock Exchange under the symbol XON. The company’s shares closed today at $45.46,…
-
Biomedical Accelerator Accepts 12 New Research Projects (Updated)
20 August 2015, Updated 21 August 2015 (see below). The Blavatnik Biomedical Accelerator at Harvard University is adding 12 new campus research projects to transform their findings into marketable products and services. The accelerator aims to bridge the gap between academic labs and venture financing, often called the Valley of Death because of the lack…
-
Antibodies to Treat Cancer Complication Licensed to Pharma
17 August 2015. Aveo Oncology, a developer of biopharmaceuticals for cancer and related diseases, is licensing its engineered antibody designed to treat cachexia, a complication of cancer and other disorders, to the pharmaceutical company Novartis. The agreement could bring Aveo as much as $326 million over the course of the collaboration. Cachexia is a metabolic…
-
Oilseed Plant Engineered for Biofuel, Chemical Feedstocks
14 August 2015. A biochemistry lab at Kansas State University genetically engineered camelina oilseed plants to make them better feedstocks for biofuels and chemicals. The team led by Kansas State professor Timothy Durrett published its findings in the August issue of the journal Plant Biotechnology Journal (paid subscription required). Durrett, with colleagues from University of…
-
Blood Disease Biotech Gains $120 Million in IPO
12 August 2015. Global Blood Therapeutics, a biotechnology company developing treatments for blood-related disorders, is raising $120 million in its initial public stock offering. The company, in South San Francisco, California and trading on the Nasdaq exchange under the symbol GBT, issued 6 million shares priced at $20.00. Shares closed today trading at $43.50, more…